JPWO2019038215A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019038215A5
JPWO2019038215A5 JP2020511371A JP2020511371A JPWO2019038215A5 JP WO2019038215 A5 JPWO2019038215 A5 JP WO2019038215A5 JP 2020511371 A JP2020511371 A JP 2020511371A JP 2020511371 A JP2020511371 A JP 2020511371A JP WO2019038215 A5 JPWO2019038215 A5 JP WO2019038215A5
Authority
JP
Japan
Prior art keywords
atoms
alkyl
nch
groups
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020511371A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531531A5 (https=
JP7287952B2 (ja
JP2020531531A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/072398 external-priority patent/WO2019038215A1/en
Publication of JP2020531531A publication Critical patent/JP2020531531A/ja
Publication of JP2020531531A5 publication Critical patent/JP2020531531A5/ja
Publication of JPWO2019038215A5 publication Critical patent/JPWO2019038215A5/ja
Application granted granted Critical
Publication of JP7287952B2 publication Critical patent/JP7287952B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020511371A 2017-08-21 2018-08-20 アデノシン受容体アンタゴニストとしてのベンズイミダゾール誘導体 Active JP7287952B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187101 2017-08-21
EP17187101.5 2017-08-21
PCT/EP2018/072398 WO2019038215A1 (en) 2017-08-21 2018-08-20 BENZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

Publications (4)

Publication Number Publication Date
JP2020531531A JP2020531531A (ja) 2020-11-05
JP2020531531A5 JP2020531531A5 (https=) 2023-02-02
JPWO2019038215A5 true JPWO2019038215A5 (https=) 2023-02-02
JP7287952B2 JP7287952B2 (ja) 2023-06-06

Family

ID=59677148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020511371A Active JP7287952B2 (ja) 2017-08-21 2018-08-20 アデノシン受容体アンタゴニストとしてのベンズイミダゾール誘導体

Country Status (14)

Country Link
US (2) US11453647B2 (https=)
EP (1) EP3672952B1 (https=)
JP (1) JP7287952B2 (https=)
KR (1) KR20200043433A (https=)
CN (1) CN110997662B (https=)
AU (1) AU2018320673B2 (https=)
BR (1) BR112020003594A2 (https=)
CA (1) CA3073333A1 (https=)
ES (1) ES2940408T3 (https=)
IL (1) IL272637B2 (https=)
SG (1) SG11202001337XA (https=)
TW (1) TWI791593B (https=)
WO (1) WO2019038215A1 (https=)
ZA (1) ZA202001780B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019152437A1 (en) 2018-01-30 2019-08-08 Foghorn Therapeutics Inc. Compounds and uses thereof
WO2020160100A1 (en) 2019-01-29 2020-08-06 Foghorn Therapeutics Inc. Compounds and uses thereof
US20230121497A1 (en) * 2020-01-29 2023-04-20 Foghorn Therapeutics Inc. Compounds and uses thereof
CA3167275A1 (en) 2020-01-29 2021-08-05 Foghorn Therapeutics Inc. Compounds and uses thereof
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
AU2022214582C1 (en) * 2021-01-29 2025-02-27 Korea Research Institute Of Chemical Technology Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as active ingredient
JP2024509268A (ja) 2021-03-09 2024-02-29 フォグホーン セラピューティクス インコーポレイテッド 結晶形、それらを含有する組成物、及びそれらの使用方法
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
WO2022258622A1 (en) 2021-06-07 2022-12-15 Ares Trading S.A. Combination treatment of cancer
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
EP4714938A1 (en) * 2023-05-15 2026-03-25 Wigen Biomedicine Technology (Shanghai) Co., Ltd. Hdac1/2 selective inhibitor and use thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207554A (en) 1972-08-04 1980-06-10 Med-El Inc. Method and apparatus for automated classification and analysis of cells
US4125828A (en) 1972-08-04 1978-11-14 Med-El Inc. Method and apparatus for automated classification and analysis of cells
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
BR9707495A (pt) 1996-02-13 1999-07-27 Zeneca Ltd Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
US6291455B1 (en) 1996-03-05 2001-09-18 Zeneca Limited 4-anilinoquinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
AU1688599A (en) 1998-01-05 1999-07-26 Eisai Co. Ltd. Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6841549B1 (en) 1999-07-02 2005-01-11 Eisai Co., Ltd. Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
IL153484A0 (en) 2000-07-07 2003-07-06 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors
CN1255392C (zh) 2000-07-07 2006-05-10 安吉奥金尼药品有限公司 作为血管生成抑制剂的秋水仙醇衍生物
WO2004089942A2 (en) 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
EP1465634B1 (en) 2001-12-12 2014-10-22 The Government of the United States of America, as represented by the Secretary Department of Health and Human Services Methods for using adenosine receptor inhibitors to enhance immune response and inflammation
EP1618108A2 (en) 2003-04-09 2006-01-25 Biogen Idec MA Inc. Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists
AU2004238508B2 (en) 2003-05-13 2009-11-19 F. Hoffmann-La Roche Ag Imidazo-benzothiazoles
JP4444290B2 (ja) 2003-05-19 2010-03-31 エフ.ホフマン−ラ ロシュ アーゲー アデノシン受容体リガンドとしてのベンゾチアゾール誘導体
PL1628662T3 (pl) 2003-05-21 2007-07-31 Hoffmann La Roche Pochodne benzotiazolu i ich zastosowanie w leczeniu chorób związanych z receptorem adenozynowym A2A
BRPI0414266A (pt) 2003-09-19 2006-11-07 Hoffmann La Roche derivados de tiazolopiridina como ligandos receptores da adenosina
CN1956983B (zh) 2004-05-24 2010-05-26 弗·哈夫曼-拉罗切有限公司 4-羟基-4-甲基-哌啶-1-甲酸(4-甲氧基-7-吗啉-4-基-苯并噻唑-2-基)-酰胺
CN1989139B (zh) 2004-07-22 2010-05-12 弗·哈夫曼-拉罗切有限公司 苯并噻唑衍生物
ES2400287T3 (es) 2005-03-14 2013-04-08 High Point Pharmaceuticals, Llc Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa
CN102731488A (zh) * 2011-04-02 2012-10-17 中国医学科学院药物研究所 苯并咪唑类衍生物、及其制法和药物组合物与用途

Similar Documents

Publication Publication Date Title
JPWO2019038215A5 (https=)
JP2021514001A5 (https=)
JP2004525117A5 (https=)
JP2018048209A5 (https=)
JPWO2019038214A5 (https=)
JP2005523922A5 (https=)
JP2021535177A5 (https=)
CA2457054A1 (en) Activator of peroxisome proliferator-activated receptor .delta.
JP2009536221A5 (https=)
RU2009102252A (ru) Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с
JP2010532768A5 (https=)
JPWO2023060253A5 (https=)
JP2021535174A5 (https=)
JP2009541225A5 (https=)
JP2020528922A5 (https=)
JP2011517697A5 (https=)
JP2005503435A5 (https=)
JP2008543781A5 (https=)
JPWO2022256434A5 (https=)
JPH10316662A5 (https=)
JP2006513222A5 (https=)
JPWO2019025099A5 (https=)
JP2012519703A5 (https=)
JPH1081664A5 (https=)
RU2007112501A (ru) Бензимидазольные производные, содержащие их композиции, их получение и применение